Enliven Therapeutics Correlations

ELVN Stock

21.27 0.41 1.97%

The current 90-days correlation between Enliven Therapeutics and Cullinan Oncology LLC is 0.29 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enliven Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enliven Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Enliven Therapeutics Correlation With Market

Average diversification

The correlation between Enliven Therapeutics and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enliven Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Enliven Stock, please use our How to Invest in Enliven Therapeutics guide.

Moving together with Enliven Stock

0.79	JNJ	Johnson Johnson	Pair Corr
0.9	INZY	Inozyme Pharma	Pair Corr
0.61	KRYS	Krystal Biotech	Pair Corr
0.64	LPTX	Leap Therapeutics	Pair Corr
0.86	MREO	Mereo BioPharma Group	Pair Corr
0.88	NKTX	Nkarta Inc	Pair Corr
0.95	PDSB	PDS Biotechnology Corp	Pair Corr
0.7	PLRX	Pliant Therapeutics	Pair Corr
0.67	ABBV	AbbVie Inc Earnings Call Tomorrow	Pair Corr
0.94	ABOS	Acumen Pharmaceuticals	Pair Corr
0.83	ADAP	Adaptimmune Therapeutics	Pair Corr
0.87	AFMD	Affimed NV	Pair Corr
0.85	AMGN	Amgen Inc Earnings Call This Week	Pair Corr
0.82	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.81	APTO	Aptose Biosciences	Pair Corr
0.64	STOK	Stoke Therapeutics	Pair Corr
0.81	BDTX	Black Diamond Therap	Pair Corr
0.78	TERN	Terns Pharmaceuticals Buyout Trend	Pair Corr
0.73	CRVS	Corvus Pharmaceuticals	Pair Corr
0.86	DAWN	Day One Biopharmaceu	Pair Corr
0.91	ACET	Adicet Bio	Pair Corr

Moving against Enliven Stock

0.62	BMY	Bristol Myers Squibb Earnings Call This Week	Pair Corr
0.61	MLAB	Mesa Laboratories Earnings Call This Week	Pair Corr
0.39	GILD	Gilead Sciences Earnings Call This Week	Pair Corr
0.72	CDXS	Codexis	Pair Corr
0.46	PTCT	PTC Therapeutics	Pair Corr
0.46	BPMC	Blueprint Medicines Corp Sell-off Trend	Pair Corr
0.74	MNPR	Monopar Therapeutics	Pair Corr
0.58	DNA	Ginkgo Bioworks Holdings Upward Rally	Pair Corr
0.35	DNOW	Now Inc	Pair Corr

Related Correlations Analysis

	THRX	PMVP	CGEM	IMRX	AVTE	MLTX	GPCR	CMPX	REPL	NVCT
THRX		0.6	0.55	-0.15	0.09	0.28	0.42	-0.71	-0.44	0.21	THRX
PMVP	0.6		0.84	-0.09	0.08	0.44	0.81	-0.57	0.15	0.42	PMVP
CGEM	0.55	0.84		-0.16	-0.16	0.11	0.91	-0.35	0.0	0.67	CGEM
IMRX	-0.15	-0.09	-0.16		0.09	0.23	-0.27	-0.09	0.22	-0.24	IMRX
AVTE	0.09	0.08	-0.16	0.09		0.45	-0.12	-0.14	0.21	-0.23	AVTE
MLTX	0.28	0.44	0.11	0.23	0.45		0.08	-0.66	0.4	-0.26	MLTX
GPCR	0.42	0.81	0.91	-0.27	-0.12	0.08		-0.23	0.13	0.54	GPCR
CMPX	-0.71	-0.57	-0.35	-0.09	-0.14	-0.66	-0.23		0.16	0.21	CMPX
REPL	-0.44	0.15	0.0	0.22	0.21	0.4	0.13	0.16		-0.06	REPL
NVCT	0.21	0.42	0.67	-0.24	-0.23	-0.26	0.54	0.21	-0.06		NVCT
	THRX	PMVP	CGEM	IMRX	AVTE	MLTX	GPCR	CMPX	REPL	NVCT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GPCR	+ 0.91	CGEM
CGEM	+ 0.84	PMVP
GPCR	+ 0.81	PMVP
NVCT	+ 0.67	CGEM
PMVP	+ 0.6	THRX
CGEM	+ 0.55	THRX

High negative correlations

CMPX	- 0.71	THRX
CMPX	- 0.66	MLTX
CMPX	- 0.57	PMVP
REPL	- 0.44	THRX
CMPX	- 0.35	CGEM
GPCR	- 0.27	IMRX

Risk-Adjusted Indicators

There is a big difference between Enliven Stock performing well and Enliven Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enliven Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
THRX	5.44	(0.38)	0.00	0.23	0.00	0.00	11.75	(8.57)	90.33
PMVP	1.86	(0.20)	0.00	(0.23)	0.00	0.00	4.35	(4.57)	12.59
CGEM	2.92	(0.45)	0.00	(3.93)	0.00	0.00	5.13	(7.10)	17.21
IMRX	4.04	(0.09)	0.00	(0.05)	0.00	0.00	10.10	(7.77)	30.20
AVTE	2.01	0.27	0.10	2.54	1.71	(2.94)	5.53	(3.31)	18.16
MLTX	2.57	0.02	(0.01)	0.41	3.44	(2.53)	4.74	(5.69)	15.60
GPCR	3.04	(0.31)	0.00	(0.26)	0.00	0.00	7.11	(7.98)	22.37
CMPX	5.10	0.89	0.17	0.41	5.04	(5.68)	14.18	(9.49)	44.59
REPL	3.35	0.25	0.09	0.21	3.28	(4.06)	8.45	(5.26)	46.30
NVCT	4.85	(0.22)	(0.01)	0.00	9.79	(4.71)	9.69	(10.50)	75.91

Enliven Therapeutics Corporate Executives

Elected by the shareholders, the Enliven Therapeutics' board of directors comprises two types of representatives: Enliven Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enliven. The board's role is to monitor Enliven Therapeutics' management team and ensure that shareholders' interests are well served. Enliven Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enliven Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Joseph Lyssikatos	CoFounder Officer	Profile
Benjamin Hohl	CFO Development	Profile
Anish PharmD	CoFounder COO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC